| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/14/2005 | US20050153446 Culturing and differentiating neural precursor cells |
| 07/14/2005 | US20050153445 System for expanding and differentiating human embryonic stem cells |
| 07/14/2005 | US20050153444 Using fibroblast growth factor to establish a line of embryonic stem cells |
| 07/14/2005 | US20050153443 Using cell mass, pluripotent and/or multipotent stem cells to propagate preferential mammalian cells or tissues; regenerative medicine; tissue engineering; tissue targeted therapy |
| 07/14/2005 | US20050153442 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153441 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153440 Using embryonic germ cell as model for monittoring and evaluating genomic imprinting; tissue engineering; tissue targeted therapy; regenerative medicine; gene silencing |
| 07/14/2005 | US20050153439 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 07/14/2005 | US20050153437 Method for controlling biological function with mechanical vibration and device therefor |
| 07/14/2005 | US20050153429 Cell adhesion resisting surfaces |
| 07/14/2005 | US20050153419 Host cells designed for efficient propagation and recovering of viral particles |
| 07/14/2005 | US20050153414 Regulator of G-protein signaling (RGS) polypeptide for use as tools in identifying modulators of cell signaling; antitumor agents; mimetics |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153394 Targeting construct for use as tool in enhanced transfer gene sequences into cells; bioreactors; improving exogenous gene expression |
| 07/14/2005 | US20050153392 Transgenesis with humanized immunoglobulin loci |
| 07/14/2005 | US20050153378 Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153372 Using calmodulin-dependent protein kinase and/or calcineurin as tool in detecting modulators of nervous system and brain disorders; enzyme inhibitors |
| 07/14/2005 | US20050153367 Method of detecting immune response |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153342 Using cell-adhesion matrix to isolate and propagate tumlor cells; blood filters |
| 07/14/2005 | US20050153338 Using polymerase chain chimerization to direct evolution of enhanced biopolymer molecules; directed protein evolution |
| 07/14/2005 | US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders |
| 07/14/2005 | US20050153330 Novel DKR polypeptides |
| 07/14/2005 | US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders |
| 07/14/2005 | US20050153310 Luciferase biosensor |
| 07/14/2005 | US20050153280 Viral propagation system and uses thereof |
| 07/14/2005 | US20050153004 plant extracts used as adjuvants for DNA vaccines, to improve immune responses in mammals |
| 07/14/2005 | US20050152984 Membrane scaffold proteins |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/14/2005 | US20050152917 Fusion protein for use in the treatment of viral diseases |
| 07/14/2005 | US20050152916 Antigen presenting system and methods for activation of T-cells |
| 07/14/2005 | US20050152904 Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor |
| 07/14/2005 | US20050152903 antibodies or FAB fragments that specifically binds to high mobility group box (HMGB) proteins but does not specifically bind to non-A box epitopes of HMGB; inhibiting release of proinflammatory cytokine from from a vertebrate cell treated with high mobility group protein |
| 07/14/2005 | US20050152899 EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 07/14/2005 | US20050152898 Provides for modified forms of anti-CD52 antibodies with reduced numbers of potential T-cell epitopes that are expected to display decreased immunogenicity, for therapy of autoimmune conditions |
| 07/14/2005 | US20050152893 Methods and materials for the inhibition of transplant rejection |
| 07/14/2005 | US20050152886 Autologous fibrin sealant and method for making the same |
| 07/14/2005 | US20050152883 isolation of ligament cells, then culturing, recovering and implanting the cells into patients |
| 07/14/2005 | US20050152882 Particulate cartilage system |
| 07/14/2005 | US20050152881 Composition of matrix suitable for implantation in humans defatting shredded allogenic human muscle tissues |
| 07/14/2005 | US20050152880 Matrix composition for human grafts/implants |
| 07/14/2005 | US20050152839 Methods for isolation of proanthocyanidins from flavonoid-producing cell culture |
| 07/14/2005 | US20050150161 Method to improve manufactured seed germination |
| 07/14/2005 | CA2807342A1 Definitive endoderm |
| 07/14/2005 | CA2552229A1 Basal medium for es cell culturing |
| 07/14/2005 | CA2551920A1 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | CA2551915A1 Il-7 fusion proteins |
| 07/14/2005 | CA2551696A1 Immunopotentiator and method of enhancing immunoactivity using the same |
| 07/14/2005 | CA2551259A1 A process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells |
| 07/14/2005 | CA2551026A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 07/14/2005 | CA2550961A1 Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue |
| 07/14/2005 | CA2550933A1 Methods for identifying functional antibodies |
| 07/14/2005 | CA2550651A1 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | CA2550383A1 Methods and compositions for directing migration of neural progenitor cells |
| 07/14/2005 | CA2550326A1 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/14/2005 | CA2550301A1 Tissue regeneration method |
| 07/14/2005 | CA2549394A1 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
| 07/14/2005 | CA2548940A1 Process for the production of tumor necrosis factor-binding proteins |
| 07/14/2005 | CA2548757A1 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | CA2545722A1 Methods of treating asthma |
| 07/13/2005 | EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553175A1 Cephalosporin C acylase mutants |
| 07/13/2005 | EP1553174A2 Enzymes and detergent compositons |
| 07/13/2005 | EP1553173A2 Enzymes and detergent compositions |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552847A1 Inhibitors for continuous activation of calcineurin |
| 07/13/2005 | EP1552741A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds |
| 07/13/2005 | EP1552305A2 Polypeptide immobilization |
| 07/13/2005 | EP1552298A2 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 07/13/2005 | EP1552269A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 07/13/2005 | EP1552019A2 Cancer diagnostics and prognostics |
| 07/13/2005 | EP1551991A2 Functional cardiomyocytes from human embryonic stem cells |
| 07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551970A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551959A2 Modulators of chloride intracellular channel 1 protein signaling |
| 07/13/2005 | EP1551958A2 Bone marrow cell differentiation |
| 07/13/2005 | EP1551957A2 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 07/13/2005 | EP1551956A2 Methods and systems for extended in vitro culture of neuronal cells |
| 07/13/2005 | EP1551955A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 07/13/2005 | EP1551954A1 Cell culture |
| 07/13/2005 | EP1551953A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 07/13/2005 | EP1551951A1 Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
| 07/13/2005 | EP1551948A1 Culture dish and bioreactor system |
| 07/13/2005 | EP1551877A2 Taci antibodies and uses thereof |
| 07/13/2005 | EP1551876A2 Antibodies that bind cell-associated ca 125/0722p and methods of use thereof |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551867A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 07/13/2005 | EP1551859A2 Aav itr-mediated modulation |
| 07/13/2005 | EP1551857A2 A robust, inducible cardiac preferred expression system for transgenesis |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 07/13/2005 | EP1551443A2 Proteins involved in the regulation of energy homeostasis |
| 07/13/2005 | EP1551440A2 Uses of human zven proteins and polynucleotides |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551225A2 Cryopreservation of haptenized tumor cells |